Form 4: Biogen Director William Hawkins Boosts Stake with 2,370 Share Acquisition
Insider Transaction Report
Biogen Inc. Director William A. Hawkins reported the acquisition of 2,370 shares of common stock, increasing his direct beneficial ownership to 8,860 shares.
Summary
- William A. Hawkins, a Director of Biogen Inc. (BIIB), acquired 2,370 shares of common stock.
- The transaction occurred on June 17, 2025.
- The shares were acquired at a price of $0 per share, typically indicating a grant or award.
- Following this transaction, Mr. Hawkins directly beneficially owns a total of 8,860 shares of Biogen common stock.
Sentiment
Score: 6
Explanation: The sentiment is mildly positive as a director increasing their stake, even through a grant, can be interpreted as a sign of confidence. However, it is a routine disclosure and not indicative of significant new information.
Positives
- The acquisition of additional shares by a director, even if granted, aligns the insider's interests more closely with those of shareholders, potentially signaling confidence in the company's future.
Future Outlook
This Form 4 filing, which reports an insider's change in beneficial ownership, does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
Insider transactions, such as the acquisition of shares by a director, are a routine part of corporate governance across all industries. This specific filing reflects a change in an individual's stake rather than a broader industry trend or competitive development.
Related Party Transactions
- The acquisition of shares by William A. Hawkins, a Director of Biogen Inc., constitutes a related party transaction as it involves an insider of the company.
Stakeholder Impact
- Shareholders may view the increased direct ownership by a director as a positive signal, indicating alignment of interests and potential confidence in the company's long-term prospects.
Key Dates
| Date | Description |
|---|---|
| 06/17/2025 | Date of transaction for the acquisition of common stock by William A. Hawkins. |
| 06/18/2025 | Date the Form 4 was signed by Wendell Taylor, Attorney in Fact for William Allen Hawkins III. |
Keywords
Biogen, BIIB, Form 4, Insider Transaction, Stock Acquisition, Director, Common Stock, Beneficial Ownership, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.